|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02192 MEDLIVE
Nominal 
9.040 -0.170 (-1.846%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 101,866 | 77,189 | 44,433 | 111,048 |
| Net Cash from / (used in) Investing Activities | -- | (634,945) | (3,585,555) | (50,541) | 13 |
| Net Cash from / (used in) Financing Activities | -- | (133,130) | (22,380) | 3,792,050 | (2,834) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (666,209) | (3,530,746) | 3,785,942 | 108,227 |
| Cash & Cash Equivalents at beginning of period | -- | 678,245 | 3,879,104 | 147,095 | 38,883 |
| Effect of Foreign Exchange Rate Changes | -- | 63,056 | 329,887 | (53,933) | (15) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 75,092 | 678,245 | 3,879,104 | 147,095 |
| Remarks: | Real time quote last updated: 22/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 146,719,000 |
| %Change | 48.624% |
| EPS / (LPS) | RMB 0.202 |
| NBV Per Share (¥) | RMB 6.439 |